Subhash C. Chauhan, PhD, a professor in the Departments of Pharmaceutical Sciences and Pathology in the UTHSC Colleges of Pharmacy and Medicine at the University of Tennessee Health Science Center (UTHSC), has received two grants totaling $3.4 million to develop targeted nanomedicine for pancreatic cancer. Pancreatic cancer is the fourth leading cause of cancer-related deaths in… Read More
Linda Myers, MD, of the University of Tennessee Health Science Center (UTHSC) has received a grant totaling $1.67 million for research into autoimmune arthritis. Dr. Myers, a professor in the Department of Pediatrics in the UTHSC College of Medicine, hopes her work will lead to the development of new therapeutic approaches. Rheumatoid arthritis (RA) is an inflammatory disorder of unknown… Read More
Shea Harrison, a fourth-year College of Medicine student at UT Health Science Center, can offer an interesting perspective on her chosen field. Through a research effort spearheaded by George Pantalos, PhD, a professor of surgery and bioengineering at the University of Louisville, Harrison is learning about surgery during space missions. She is participating in the… Read More
Mahul Amin, MD, has been named chair of the Department of Pathology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC). He will also be the UTHSC Gerwin Chair for cancer research. Dr. Amin comes to UTHSC from Cedars-Sinai Medical Center, where he was chairman and professor of Pathology and… Read More
R. Bruce Shack, MD, has been named dean of the University of Tennessee Health Science Center (UTHSC) College of Medicine in Chattanooga and Senior Vice President of the Erlanger Health System. Dr. Shack comes to UTHSC after serving almost 20 years as chair and a professor of the Department of Plastic Surgery at Vanderbilt University… Read More
Meiyun Fan, MD, PhD, an associate professor of Pathology at The University of Tennessee Health Science Center (UTHSC), has received a $100,000 grant from the National Cancer Institute to study an aggressive form of breast cancer known as Basal-Like Breast Cancer, or BLBC. The grant will be distributed over two years. Approximately 40 percent of… Read More